Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology

ORCID: 0000-0002-1531-4294

Publication year:
All
101 - 200 out of 508Page size: 100
  1. 2023
  2. Published

    The effect of diabetes and the diabetogenic TBC1D4 p.Arg684ter variant on kidney function in Inuit in Greenland

    Overvad, M., Díaz, L. J., Bjerregaard, P., Pedersen, M. L., Larsen, C. V. L., Grarup, Niels, Hansen, Torben, Rossing, Peter & Jørgensen, M. E., 2023, In: International Journal of Circumpolar Health. 82, 8 p., 2191406.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    The effects of empagliflozin on measured glomerular filtration rate and estimated extracellular and plasma volumes in patients with type 2 diabetes

    Jürgens, M., Schou, Morten, Hasbak, P., Kjær, Andreas, Wolsk, E., Zerahn, B., Brandt-Jacobsen, N. H., Gæde, P., Rossing, Peter, Faber, Jens, Inzucchi, S. E., Gustafsson, Finn & Kistorp, Caroline Michaela Nervil, 2023, In: Diabetes, Obesity and Metabolism. 25, 10, p. 2888-2896 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study

    Rossing, Peter, Anker, S. D., Filippatos, G., Pitt, B., Ruilope, L. M., Billings, L. K., Green, J. B., Koya, D., Mosenzon, O., Pantalone, K. M., Ahlers, C., Lage, A., Lawatscheck, R., Scalise, A. & Bakris, G. L., 2023, In: Diabetes, Obesity and Metabolism. 25, 10, p. 2989-2998 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease

    on behalf of the FLOW Steering Committee and FLOW Trial Investigators, O. B. O. T. F. S. C. A. F. T. I., 2023, In: Nephrology Dialysis Transplantation. 38, 9, p. 2041-2051 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Time Trends in the Incidence of Diabetic Ketoacidosis Leading to Hospital Admission Among Adults With Type 1 Diabetes: A Nationwide Danish Register Study

    Stougaard, E. B., Amadid, H., Søndergaard, E., Carstensen, Bendix, Jørgensen, M. E., Nørgaard, Kirsten, Rossing, Peter, Persson, F. & Vistisen, D., 2023, In: Diabetes Care. 46, 11, p. 1897-1902 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Vitamin D deficiency and development of complications in individuals with type 1 and type 2 diabetes: A cohort study

    Tougaard, N. H., Hansen, T. W. & Rossing, Peter, 2023, In: Journal of Diabetes and its Complications. 37, 10, 6 p., 108611.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. 2022
  9. Published

    Endotrophin as a Marker of Complications in a Type 2 Diabetes Cohort

    Tougaard, N. H., Møller, A. L., Rønn, P. F., Hansen, T. W., Genovese, F., Karsdal, M. A., Rasmussen, D. G. K. & Rossing, Peter, Nov 2022, In: Diabetes Care. 45, 11, p. 2746-2748 3 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    The importance of addressing multiple risk markers in type 2 diabetes: Results from the LEADER and SUSTAIN 6 trials

    Zobel, E. H., von Scholten, B. J., Hansen, T. W., Persson, F., Rasmussen, S., Wolthers, B. & Rossing, Peter, Feb 2022, In: Diabetes, Obesity and Metabolism. 24, 2, p. 281-288 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    16-LB: Effects of Finerenone in Patients with CKD and T2D Are Independent of HbA1c at Baseline, HbA1c Variability, and Duration of Diabetes

    Mcgill, J. B., Agarwal, R., Anker, S., Bakris, G., Filippatos, G., Pitt, B., Ruilope, L. M., Birkenfeld, A. L., Caramori, L., Brinker, M. D., Joseph, A., Lage, A. Z., Lawatscheck, R., Scott, C. & Rossing, Peter, 2022, In: Diabetes. 71, Supplement_1, 16-LB.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  12. Published

    A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

    Heerspink, H. J. L. & DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2022, In: Kidney International. 101, 1, p. 174-184 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    Acute and Long-Term Treatment With Dapagliflozin and Association With Serum Soluble Urokinase Plasminogen Activator Receptor

    Rotbain Curovic, V., Houlind, Morten Baltzer, Hansen, T. W., Eugen-Olsen, J., Laursen, J. C., Eickhoff, M. K., Persson, F. & Rossing, Peter, 2022, In: Frontiers in Pharmacology. 13, 799915.

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. Published

    Association between plasma apolipoprotein M and cardiac autonomic neuropathy in type 1 diabetes

    Safi, M., Borup, A., Stevns Hansen, C., Rossing, Peter, Thorsten Jensen, M. & Christoffersen, Christina, 2022, In: Diabetes Research and Clinical Practice. 189, 7 p., 109943.

    Research output: Contribution to journal › Journal article › Research › peer-review

  15. Published

    Association of Finerenone Use With Reduction in Treatment-Emergent Pneumonia and COVID-19 Adverse Events Among Patients With Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Pooled Secondary Analysis

    Pitt, B., Agarwal, R., Anker, S. D., Ruilope, L. M., Rossing, Peter, Ahlers, C., Brinker, M., Joseph, A., Lambelet, M., Lawatscheck, R. & Filippatos, G. S., 2022, In: JAMA network open. 5, 10, 10 p., E2236123.

    Research output: Contribution to journal › Journal article › Research › peer-review

  16. Published

    Baseline risk markers and visit-to-visit variability in relation to kidney outcomes - A post-hoc analysis of the PERL study

    Curovic, V. R., Roy, N., Hansen, T. W., Caramori, M. L., Cherney, D. Z., Boer, I. H. D., Emanuele, M. A., Hirsch, I. B., Lingvay, I., Mcgill, J. B., Polsky, S., Pop-Busui, R., Sigal, R. J., Tuttle, K. R., Umpierrez, G. E., Wallia, A., Rosas, S. E. & Rossing, Peter, 2022, In: Diabetes Research and Clinical Practice. 193, 8 p., 110119.

    Research output: Contribution to journal › Journal article › Research › peer-review

  17. Published

    Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes

    Ruilope, L. M., Agarwal, R., Anker, S. D., Filippatos, G., Pitt, B., Rossing, Peter, Sarafidis, P., Schmieder, R. E., Joseph, A., Rethemeier, N., Nowack, C., Bakris, G. L. & the FIDELIO-DKD Investigators, T. F. I., 2022, In: Hypertension. 79, 12, p. 2685-2695 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  18. Published

    Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Is Associated With Disturbances in TCA, Lipid, and Glucose Metabolism

    Hansen, C. S., Suvitaival, T., Theilade, Karen Simone, Mattila, I., Lajer, M., Trošt, K., Ahonen, L., Hansen, T. W., Legido-Quigley, C., Rossing, Peter & Ahluwalia, Tarun Veer Singh, 2022, In: Frontiers in Endocrinology. 13, 831793.

    Research output: Contribution to journal › Journal article › Research › peer-review

  19. Published

    Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: The FIDELITY pooled analysis

    Agarwal, R., Filippatos, G., Pitt, B., Anker, S. D., Rossing, Peter, Joseph, A., Kolkhof, P., Nowack, C., Gebel, M., Ruilope, L. M. & Bakris, G. L., 2022, In: European Heart Journal. 43, 6, p. 474-484 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  20. Published

    Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes

    Ferreira-Divino, L. F., Suvitaival, T., Curovic, V. R., Tofte, N., Trošt, K., Mattila, I. M., Theilade, Karen Simone, Winther, S. A., Hansen, T. W., Frimodt-Møller, M., Legido-Quigley, C. & Rossing, Peter, 2022, In: Cardiovascular Diabetology. 21, 10 p., 135.

    Research output: Contribution to journal › Journal article › Research › peer-review

  21. Published

    Clinical perspective—evolving evidence of mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes

    Rossing, Peter, 2022, In: Kidney International Supplements. 12, 1, p. 27-35 9 p.

    Research output: Contribution to journal › Review › Research › peer-review

  22. Published

    Copeptin and renal function decline, cardiovascular events and mortality in type 1 diabetes

    Heinrich, N. S., Theilade, S., Winther, S. A., Tofte, N., Ahluwalia, Tarun Veer Singh, Jeppesen, J. L., Persson, F., Hansen, T. W., Goetze, Jens P. & Rossing, Peter, 2022, In: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 37, 1, p. 100–107

    Research output: Contribution to journal › Journal article › Research › peer-review

  23. Published

    Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with CKD

    the DAPA-CKD Trial Committees and Investigators, T. D. T. C. A. I., 2022, In: Journal of the American Society of Nephrology. 33, 11, p. 2094-2107 14 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  24. Published

    Dapagliflozin Improves the Urinary Proteomic Kidney-Risk Classifier CKD273 in Type 2 Diabetes with Albuminuria: A Randomized Clinical Trial

    Curovic, V. R., Eickhoff, M. K., Rönkkä, T., Frimodt-Møller, M., Hansen, T. W., Mischak, H., Rossing, Peter, Ahluwalia, Tarun Veer Singh & Persson, F., 2022, In: Diabetes Care. 45, 11, p. 2662-2668 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  25. Published

    Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials

    Rossing, P., Inzucchi, S. E., Vart, P., Jongs, N., Docherty, K. F., Jhund, P. S., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Solomon, S. D., DeMets, D. L., Bengtsson, O., Lindberg, M., Langkilde, A. M., Sjöstrand, M., Stefansson, B. V., Karlsson, C., Chertow, G. M. & 7 others, Hou, F. F., Correa-Rotter, R., Toto, R. D., Wheeler, D. C., McMurray, J. J. V., Heerspink, H. J. L. & DAPA-CKD and DAPA-HF Trial Committees and Investigators, D. A. D. T. C. A. I., 2022, In: The Lancet Diabetes and Endocrinology. 10, 1, p. 24-34 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  26. Published

    Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)

    de Boer, I. H., Khunti, K., Sadusky, T., Tuttle, K. R., Neumiller, J. J., Rhee, C. M., Rosas, S. E., Rossing, Peter & Bakris, G., 2022, In: Diabetes Care. 45, 12, p. 3075-3090

    Research output: Contribution to journal › Journal article › Research › peer-review

  27. Published

    Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)

    de Boer, I. H., Khunti, K., Sadusky, T., Tuttle, K. R., Neumiller, J. J., Rhee, C. M., Rosas, S. E., Rossing, Peter & Bakris, G., 2022, In: Kidney International. 102, 5, p. 974-989 16 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  28. Published

    Diagnostic and prognostic value of the electrocardiogram in stable outpatients with type 2 diabetes

    Gregers, M. C. T., Schou, Morten, Jensen, M. T., Jensen, J., Petrie, M. C., Vilsbøll, Tina, Goetze, Jens P. , Rossing, Peter & Jørgensen, P. G., 2022, In: Scandinavian Cardiovascular Journal. 56, 1, p. 256-263 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  29. Published

    Differential and shared genetic effects on kidney function between diabetic and non-diabetic individuals

    Winkler, T. W., Rasheed, H., Teumer, A., Gorski, M., Rowan, B. X., Stanzick, K. J., Thomas, L. F., Tin, A., Hoppmann, A., Chu, A. Y., Tayo, B., Thio, C. H. L., Cusi, D., Chai, J-F., Sieber, K. B., Horn, K., Li, M., Scholz, M., Cocca, M., Wuttke, M. & 31 others, van der Most, P. J., Yang, Q., Ghasemi, S., Nutile, T., Li, Y., Pontali, G., Günther, F., Dehghan, A., Correa, A., Parsa, A., Feresin, A., de Vries, A. P. J., Zonderman, A. B., Smith, A. V., Oldehinkel, A. J., De Grandi, A., Rosenkranz, A. R., Franke, A., Teren, A., Metspalu, A., Hicks, A. A., Morris, A. P., Tönjes, A., Morgan, A., Podgornaia, A. I., Christensen, K., Lind, L., Kovacs, P., Rossing, Peter, Loos, Ruth & LifeLines Cohort Study, L. C. S., 2022, In: Communications Biology . 5, p. 580 20 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  30. Published

    Distal symmetrical polyneuropathy is present in all individuals with diabetes and foot ulcers - and does not associate with healing time

    Mizrak, H. I., Hansen, T. W., Andersen, Jonas Askø, Rossing, Peter, Rasmussen, A. & Hansen, C. S., 2022, In: Journal of Diabetes and its Complications. 36, 12, 108353.

    Research output: Contribution to journal › Journal article › Research › peer-review

  31. Published

    Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial

    Waijer, S. W., Vart, P., Cherney, D. Z. I., Chertow, G. M., Jongs, N., Langkilde, A. M., Mann, J. F. E., Mosenzon, O., McMurray, J. J. V., Rossing, Peter, Correa-Rotter, R., Stefansson, B. V., Toto, R. D., Wheeler, D. C. & Heerspink, H. J. L., 2022, In: Diabetologia. 65, 7, p. 1085-1097 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  32. Published

    Effect of empagliflozin on myocardial structure and function in patients with type 2 diabetes at high cardiovascular risk: the SIMPLE randomized clinical trial

    Ersbøll, M., Jürgens, M., Hasbak, P., Kjær, Andreas, Wolsk, E., Zerahn, B., Brandt-Jacobsen, N. H., Gæde, P., Rossing, Peter, Faber, Jens, Inzucchi, S. E., Gustafsson, Finn, Schou, Morten & Kistorp, Caroline Michaela Nervil, 2022, In: International Journal of Cardiovascular Imaging. 38, p. 579–587

    Research output: Contribution to journal › Journal article › Research › peer-review

  33. Published

    Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER

    Shaman, A. M., Bain, S. C., Bakris, G. L., Buse, J. B., Idorn, T., Mahaffey, K. W., Mann, J. F. E., Nauck, M. A., Rasmussen, S., Rossing, Peter, Wolthers, B., Zinman, B. & Perkovic, V., 2022, In: Circulation. 145, 8, p. 575-585 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  34. Published

    Effects of Butyrate Supplementation on Inflammation and Kidney Parameters in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

    Tougaard, N. H., Frimodt-Møller, M., Salmenkari, H., Stougaard, E. B., Zawadzki, A. D., Mattila, I. M., Hansen, T. W., Legido-Quigley, C., Hörkkö, S., Forsblom, C., Groop, P. H., Lehto, M. & Rossing, Peter, 2022, In: Journal of Clinical Medicine. 11, 13, 3573.

    Research output: Contribution to journal › Journal article › Research › peer-review

  35. Published

    Effects of Dapagliflozin in People without Diabetes and with Microalbuminuria

    Heerspink, H. J. L., Chertow, G. M., Jongs, N., Correa-Rotter, R., Rossing, Peter, Sjöström, C. D., Langkilde, A. M. & Wheeler, D. C., 2022, In: Clinical Journal of the American Society of Nephrology. 17, 11, p. 1665-1668 4 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  36. Published

    Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results

    Agarwal, R., Anker, S. D., Filippatos, G., Pitt, B., Rossing, Peter, Ruilope, L. M., Boletis, J., Toto, R., Umpierrez, G. E., Wanner, C., Wada, T., Scott, C., Joseph, A., Ogbaa, I., Roberts, L., Scheerer, M. F., Bakris, G. L. & FIDELIO-DKD Investigators, F. I., 2022, In: Nephrology Dialysis Transplantation. p. 1261–1269 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  37. Published

    Efficacy and Safety of Dapagliflozin in Patients With CKD Across Major Geographic Regions

    Vart, P., Correa-Rotter, R., Hou, F. F., Jongs, N., Chertow, G. M., Langkilde, A. M., McMurray, J. J. V., Rossing, Peter, Sjöström, C. D., Stefansson, B. V., Toto, R. D., Douthat, W., Escudero, E., Isidto, R., Khullar, D., Bajaj, H. S., Wheeler, D. C. & Heerspink, H. J. L., 2022, In: Kidney International Reports. 7, 4, p. 699-707 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  38. Published

    Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP-1RA treatment: A subgroup analysis from the FIDELIO-DKD trial

    Rossing, Peter, Agarwal, R., Anker, S. D., Filippatos, G., Pitt, B., Ruilope, L. M., Amod, A., Marre, M., Joseph, A., Lage, A., Scott, C., Bakris, G. L. & the FIDELIO-DKD Investigators, T. F. I., 2022, In: Diabetes, Obesity and Metabolism. 24, 1, p. 125-134 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  39. Published

    Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence

    Rossing, P., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., Sadusky, T., Tandon, N., Tuttle, K. R., Wanner, C., Wilkens, K. G., Zoungas, S., Craig, J. C., Tunnicliffe, D. J., Tonelli, M. A., Cheung, M. & 2 others, Earley, A. & de Boer, I. H., 2022, In: Kidney International. 102, 5, p. 990-999 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  40. Published

    Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial

    FIGARO DKD Investigators, F. D. I., 2022, In: Circulation. 145, 6, p. 437-447 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  41. Published

    Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and Diabetes

    Filippatos, G., Anker, S. D., Pitt, B., Rossing, Peter, Joseph, A., Kolkhof, P., Lambelet, M., Lawatscheck, R., Bakris, G. L., Ruilope, L. M. & Agarwal, R., 2022, In: JACC: Heart Failure. 10, 11, p. 860-870 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  42. Published

    Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

    Rossing, Peter, Burgess, E., Agarwal, R., Anker, S. D., Filippatos, G., Pitt, B., Ruilope, L. M., Gillard, P., Macisaac, R. J., Wainstein, J., Joseph, A., Brinker, M., Roessig, L., Scott, C., Bakris, G. L. & FIDELIO-DKD Investigators, F. I., 2022, In: Diabetes Care. 45, 4, p. 888-897 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  43. Published

    Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

    Rossing, Peter, Anker, S. D., Filippatos, G., Pitt, B., Ruilope, L. M., Birkenfeld, A. L., McGill, J. B., Rosas, S. E., Joseph, A., Gebel, M., Roberts, L., Scheerer, M. F., Bakris, G. L. & Agarwal, R., 2022, In: Diabetes Care. 45, 12, p. 2991-2998 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  44. Published

    Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy

    FIDELIO-DKD Investigators, F. I., 2022, In: Kidney International Reports. 7, 1, p. 36-45

    Research output: Contribution to journal › Journal article › Research › peer-review

  45. Published

    Finerenone in patients with chronic kidney disease and type 2 diabetes with and without heart failure: a prespecified subgroup analysis of the FIDELIO-DKD trial

    Filippatos, G., Pitt, B., Agarwal, R., Farmakis, D., Ruilope, L. M., Rossing, Peter, Bauersachs, J., Mentz, R. J., Kolkhof, P., Scott, C., Joseph, A., Bakris, G. L., Anker, S. D. & FIDELIO-DKD Investigators, F. I., 2022, In: European Journal of Heart Failure. 24, 6, p. 996-1005 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  46. Published

    Flexor Tendon Tenotomy Treatment of the Diabetic Foot: A Multicenter Randomized Controlled Trial

    Andersen, Jonas Askø, Rasmussen, A., Engberg, S., Bencke, J., Frimodt-Møller, M., Kirketerp-Møller, K. & Rossing, Peter, 2022, In: Diabetes Care. 45, 11, p. 2492-2500 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  47. Published

    Genetic loci and prioritization of genes for kidney function decline derived from a meta-analysis of 62 longitudinal genome-wide association studies

    Gorski, M., Rasheed, H., Teumer, A., Thomas, L. F., Graham, S. E., Sveinbjornsson, G., Winkler, T. W., Günther, F., Stark, K. J., Chai, J-F., Tayo, B. O., Wuttke, M., Li, Y., Tin, A., Ahluwalia, T. S., Ärnlöv, J., Åsvold, B. O., Bakker, S. J. L., Banas, B., Bansal, N. & 29 others, Biggs, M. L., Biino, G., Böhnke, M., Boerwinkle, E., Bottinger, E. P., Brenner, H., Brumpton, B., Carroll, R. J., Chaker, L., Chalmers, J., Chee, M., Chee, M., Cheng, C., Chu, A. Y., Ciullo, M., Cocca, M., Cook, J. P., Coresh, J., Cusi, D., de Borst, M. H., Degenhardt, F., Eckardt, K., Endlich, K., Evans, M. K., Feitosa, M. F., Franke, A., Freitag-Wolf, S., Rossing, Peter & LifeLines Cohort Study, L. C. S., 2022, In: Kidney International. 102, 3, p. 624-639 16 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  48. Published

    Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial

    FIDELIO-DKD Investigators, F. I., 2022, In: Journal of the American Society of Nephrology. 33, 1, p. 225-237 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  49. Published

    Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrology

    Waijer, S. W., Provenzano, M., Mulder, S., Rossing, Peter, Persson, F., Perkovic, V. & Heerspink, H. J. L., 2022, In: Diabetes, Obesity and Metabolism. 24, 6, p. 983-990 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  50. Published

    Increased mitochondrial proton leak and glycolysis in peripheral blood mononuclear cells in type-1-diabetes

    Lopes de Melo, J. M., Laursen, J. C., Søndergaard-Heinrich, N., Bull Rasmussen, I. K., Hansen, C. S., Frimodt-Møller, M., Rossing, Peter & Størling, Joachim, 2022, In: Heliyon. 8, 12, 7 p., e12304.

    Research output: Contribution to journal › Journal article › Research › peer-review

  51. Published

    Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenone

    Agarwal, R., Anker, S. D., Bakris, G., Filippatos, G., Pitt, B., Rossing, Peter, Ruilope, L., Gebel, M., Kolkhof, P., Nowack, C., Joseph, A. & FIDELIO-DKD and FIGARO-DKD Investigators, F. A. F. I., 2022, In: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 37, 6, p. 1014–1023

    Research output: Contribution to journal › Journal article › Research › peer-review

  52. Published

    KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease

    de Boer, I. H., Rossing, P., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., Sadusky, T., Tandon, N., Tuttle, K. R., Wanner, C., Wilkens, K. G., Zoungas, S., Jadoul, M., Winkelmayer, W. C., Tonelli, M. A. & 7 others, Craig, J. C., Strippoli, G. F. M., Tunnicliffe, D. J., Higgins, G. Y., Natale, P., Cooper, T. E. & Willis, N. S., 2022, In: Kidney International. 102, 5, p. S1-S127 127 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  53. Published

    Kidney oxygenation, perfusion and blood flow in people with and without type 1 diabetes

    Laursen, J. C., Søndergaard-Heinrich, N., Haddock, B., Rasmussen, I. K. B., Hansen, C. S., Larsson, Henrik Bo Wiberg, Groop, P., Bjornstad, P., Frimodt-Møller, M., Andersen, U. B. & Rossing, Peter, 2022, In: Clinical Kidney Journal. 15, 11, p. 2072-2080 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  54. Published

    Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes: A Post Hoc Analysis of the LIRAFLAME Randomized Placebo-Controlled Trial

    Wretlind, A., Zobel, E. H., De Zawadzki, A., Ripa, Rasmus Sejersten, Curovic, V. R., Von Scholten, B. J., Mattila, I. M., Hansen, T. W., Kjær, Andreas, Vestergaard, H., Rossing, Peter & Legido-Quigley, C., 2022, In: Frontiers in Clinical Diabetes and Healthcare. 3, 8 p., 856485.

    Research output: Contribution to journal › Journal article › Research › peer-review

  55. Published

    Making an impact on kidney disease in people with type 2 diabetes: the importance of screening for albuminuria

    McGill, J. B., Haller, H., Roy-Chaudhury, P., Cherrington, A., Wada, T., Wanner, C., Ji, L. & Rossing, Peter, 2022, In: BMJ open diabetes research & care. 10, 4

    Research output: Contribution to journal › Review › Research › peer-review

  56. Published

    Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., Rossing, Peter, Tankova, T., Tsapas, A. & Buse, J. B., 2022, In: Diabetes Care. 45, 11, p. 2753-2786 34 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  57. Published

    Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., Rossing, Peter, Tankova, T., Tsapas, A. & Buse, J. B., 2022, In: Diabetologia. 65, 12, p. 1925-1966 42 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  58. Published

    Microalbuminuria Constitutes a Clinical Action Item for Clinicians in 2021

    Rossing, Peter & Epstein, M., 2022, In: American Journal of Medicine. 135, 5, p. 576-580 5 p.

    Research output: Contribution to journal › Review › Research › peer-review

  59. Published

    Multiomics signatures of type 1 diabetes with and without albuminuria

    Clos-Garcia, M., Ahluwalia, Tarun Veer Singh, Winther, S. A., Henriksen, P., Ali, M., Fan, Yong, Stankevic, Evelina, Lyu, Liwei, Vogt, J. K., Hansen, Torben, Legido-Quigley, C., Rossing, Peter & Pedersen, Oluf Borbye, 2022, In: Frontiers in Endocrinology. 13, 17 p., 1015557.

    Research output: Contribution to journal › Journal article › Research › peer-review

  60. Published

    Non-dipping and higher nocturnal blood pressure are associated with risk of mortality and development of kidney disease in type 1 diabetes

    Hjortkjær, H., Persson, F., Theilade, S., Winther, S. A., Tofte, N., Ahluwalia, Tarun Veer Singh & Rossing, Peter, 2022, In: Journal of Diabetes and its Complications. 36, 9, 6 p., 108270.

    Research output: Contribution to journal › Journal article › Research › peer-review

  61. Published

    Novel topical allogeneic bone-marrow-derived mesenchymal stem cell treatment of hard-to-heal diabetic foot ulcers: a proof of concept study

    Andersen, Jonas Askø, Rasmussen, A., Frimodt-Møller, M., Engberg, S., Steeneveld, E., Kirketerp-Møller, K., O’Brien, T. & Rossing, Peter, 2022, In: Stem Cell Research and Therapy. 13, 1, 280.

    Research output: Contribution to journal › Journal article › Research › peer-review

  62. Published

    Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long-Term Response to Atrasentan in Patients With Diabetic Kidney Disease

    Smeijer, J. D., Koomen, J. V., Kohan, D. E., McMurray, J. J. V., Bakris, G. L., Correa-Rotter, R., Hou, F. F., Kitzman, D. W., Makino, H., Mayer, G., Nowicki, M., Perkovic, V., Rossing, Peter, Tobe, S., Parving, H. H., de Zeeuw, D. & Heerspink, H. J. L., 2022, In: Clinical Pharmacology and Therapeutics. 112, 5, p. 1098-1107

    Research output: Contribution to journal › Journal article › Research › peer-review

  63. Published

    Precision diagnostic approach to predict 5-year risk for microvascular complications in type 1 diabetes

    Al-Sari, N., Kutuzova, Svetlana, Suvitaival, T., Henriksen, P., Pociot, Flemming, Rossing, Peter, McCloskey, D. & Legido-Quigley, C., 2022, In: EBioMedicine. 80, 104032.

    Research output: Contribution to journal › Journal article › Research › peer-review

  64. Published

    Quételet (body mass) index and effects of dapagliflozin in chronic kidney disease

    Chertow, G. M., Vart, P., Jongs, N., Langkilde, A. M., McMurray, J. J. V., Correa-Rotter, R., Rossing, Peter, Sjöström, C. D., Stefansson, B. V., Toto, R. D., Wheeler, D. C. & Heerspink, H. J. L., 2022, In: Diabetes, Obesity and Metabolism. 24, 5, p. 827-837 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  65. Published

    Randomized Controlled Trial of the Hemodynamic Effects of Empagliflozin in Patients With Type 2 Diabetes at High Cardiovascular Risk: The SIMPLE Trial

    Wolsk, E., Jürgens, M., Schou, Morten, Ersbøll, M., Hasbak, P., Kjær, Andreas, Zerahn, B., Brandt, N. H., Gæde, P. H., Rossing, Peter, Faber, Jens, Inzucchi, S. E., Kistorp, Caroline Michaela Nervil & Gustafsson, Finn, 2022, In: Diabetes. 71, 4, p. 812-820 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  66. Published

    Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis

    Stougaard, E. B., Kristensen, Peter Lommer, Kielgast, U., Andersen, H. U., Hamid, Y., Gæde, P. H., Søndergaard, E., Dørflinger, G. H., Fjeldborg, K. K., Hansen, K. W., Thomsen, H. H., Al-Imar, T. M. J., Røder, M., Sridhar, V. S., Cherney, D., Rossing, Peter & Persson, F., 2022, In: Diabetes & vascular disease research. 19, 5, p. 14791641221130043

    Research output: Contribution to journal › Journal article › Research › peer-review

  67. Published

    Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes

    Schnell, O., Battelino, T., Bergenstal, R., Blüher, M., Böhm, M., Brosius, F., Carr, R. D., Ceriello, A., Forst, T., Giorgino, F., Guerci, B., Heerspink, H. J. L., Itzhak, B., Ji, L., Kosiborod, M., Lalić, N., Lehrke, M., Marx, N., Nauck, M., Rodbard, H. W. & 10 others, Rosano, G. M. C., Rossing, Peter, Rydén, L., Santilli, F., Schumm-Draeger, P., Vandvik, P. O., Vilsbøll, Tina, Wanner, C., Wysham, C. & Standl, E., 2022, In: Cardiovascular Diabetology. 21, 1, 50.

    Research output: Contribution to journal › Journal article › Research › peer-review

  68. Published

    Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial

    Wheeler, D. C., Jongs, N., Stefansson, B., Chertow, G. M., Greene, T., Hou, F. F., Langkilde, A. M., McMurray, J. J., Rossing, Peter, Nowicki, M., Wittmann, I., Correa-Rotter, R., Sjostrom, C. D., Toto, R. D., Heerspink, H. J. L. & DAPA-CKD Trial Comm Investigators, D. T. C. I., 2022, In: Nephrology Dialysis Transplantation. 37, 9, p. 1647–1656 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  69. Published

    Sodium–glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk engines

    Stougaard, E. B., Rossing, Peter, Cherney, D., Vistisen, D. & Persson, F., 2022, In: Journal of Diabetes and its Complications. 36, 8, 108257.

    Research output: Contribution to journal › Journal article › Research › peer-review

  70. Published

    Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, reduces the risk of cardiovascular and renal disease as assessed by Steno Risk Engines in adults with type 1 diabetes

    Stougaard, E. B., Rossing, Peter, Vistisen, D., Banks, P., Girard, M., Davies, M. J. & Persson, F., 2022, In: Diabetologia. 65, SUPPL 1, p. S47 1 p.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  71. Published

    The Kidney Protective Effects of the Sodium–Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor Antagonists

    Provenzano, M., Jongs, N., Vart, P., Stefánsson, B. V., Chertow, G. M., Langkilde, A. M., McMurray, J. J. V., Correa-Rotter, R., Rossing, Peter, Sjöström, C. D., Toto, R. D., Wheeler, D. C., Heerspink, H. J. L. & DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2022, In: Kidney International Reports. 7, 3, p. 436-443

    Research output: Contribution to journal › Journal article › Research › peer-review

  72. Published

    The authors reply

    Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group, K. D. I. G. O. (. D. W. G., 2022, In: Kidney International. 101, 2, p. 420-421 2 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  73. Published

    The effect of liraglutide on cardiac autonomic function in type 2 diabetes: A prespecified secondary analysis from the LIRAFLAME randomized, double-blinded, placebo-controlled trial

    Sivalingam, S., Hein Zobel, E., Hansen, C. S., Ripa, Rasmus Sejersten, von Scholten, B. J., Rotbain Curovic, V., Kjær, Andreas, Jensen, Jacob Kildevang, Hansen, T. W. & Rossing, Peter, 2022, In: Diabetes, Obesity and Metabolism. 24, 8, p. 1638-1642

    Research output: Contribution to journal › Letter › Research › peer-review

  74. Published

    The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus

    Puig-Jové, C., Julve, J., Castelblanco, E., Julián, M. T., Amigó, N., Andersen, H. U., Ahluwalia, Tarun Veer Singh, Rossing, Peter, Mauricio, D., Jensen, M. T. & Alonso, N., 2022, In: Cardiovascular Diabetology. 21, 257.

    Research output: Contribution to journal › Journal article › Research › peer-review

  75. Published

    The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: from randomised trials to clinical practice

    von Scholten, B. J., Kreiner, F. F., Rasmussen, S., Rossing, Peter & Idorn, T., 2022, In: Therapeutic Advances in Endocrinology and Metabolism. 13, p. 1-14

    Research output: Contribution to journal › Review › Research › peer-review

  76. Published

    Urinary Proteomics Identifies Cathepsin D as a Biomarker of Rapid eGFR Decline in Type 1 Diabetes

    Limonte, C. P., Valo, E., Drel, V., Natarajan, L., Darshi, M., Forsblom, C., Henderson, C. M., Hoofnagle, A. N., Ju, W., Kretzler, M., Montemayor, D., Nair, V., Nelson, R. G., O’toole, J. F., Toto, R. D., Rosas, S. E., Ruzinski, J., Sandholm, N., Schmidt, I. M., Vaisar, T. & 12 others, Waikar, S. S., Zhang, J., Rossing, Peter, Ahluwalia, Tarun Veer Singh, Groop, P. H., Pennathur, S., Snell-Bergeon, J. K., Costacou, T., Orchard, T. J., Sharma, K., de Boer, I. H. & Kidney Precision Medicine Project, K. P. M. P., 2022, In: Diabetes Care. 45, 6, p. 1416-1427 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  77. 2021
  78. Published

    Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial

    Zobel, E. H., Wretlind, A., Ripa, Rasmus Sejersten, Rotbain Curovic, V., von Scholten, B. J., Suvitaival, T., Hansen, T. W., Kjær, Andreas, Legido-Quigley, C. & Rossing, Peter, Sep 2021, In: BMJ open diabetes research & care. 9, 1, p. 1-9 e002395.

    Research output: Contribution to journal › Journal article › Research › peer-review

  79. Published

    Sodium-glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk engines

    Stougaard, E. B., Vistisen, D., Persson, F. & Rossing, Peter, Sep 2021, In: Diabetologia. 64, SUPPL 1, p. 319-319 1 p., 606.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  80. Published

    Response to Comment on Vistisen et al. A validated prediction model for endstage kidney disease in type 1 diabetes. Diabetes care 2021;44:901–907

    Vistisen, D., Andersen, G. S., Hulman, A., McGurnaghan, S. J., Colhoun, H. M., Henriksen, J. E., Thomsen, R. W., Persson, F., Rossing, Peter & Jørgensen, M. E., Jun 2021, In: Diabetes Care. 44, 6, p. e140-e141 2 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  81. Published

    A narrative review of new treatment options for chronic kidney disease in type 2 diabetes

    Persson, F., Borg, Rikke & Rossing, Peter, 1 Apr 2021, In: Annals of Translational Medicine. 9, 8, p. 716-716 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  82. Published

    A New Panel Estimated GFR, Including β2-Microglobulin and β-Trace Protein and Not Including Race, Developed in a Diverse Population

    CKD-EPI GFR Collaborators, C. G. C., 2021, In: American Journal of Kidney Diseases. 77, 5, p. 673-683

    Research output: Contribution to journal › Journal article › Research › peer-review

  83. Published

    A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes

    Vistisen, D., Andersen, G. S., Hulman, A., McGurnaghan, S. J., Colhoun, H. M., Henriksen, J. E., Thomsen, R. W., Persson, F., Rossing, Peter & Jørgensen, M. E., 2021, In: Diabetes Care. 44, 3, 7 p., dc202586.

    Research output: Contribution to journal › Journal article › Research › peer-review

  84. Published

    A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy

    DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2021, In: Kidney International. 100, 1, p. 215-224

    Research output: Contribution to journal › Journal article › Research › peer-review

  85. Published

    A primer on metabolic memory: Why existing diabesity treatments fail

    Copur, S., Rossing, Peter, Afsar, B., Sag, A. A., Siriopol, D., Kuwabara, M., Ortiz, A. & Kanbay, M., 2021, In: Clinical Kidney Journal. 14, 3, p. 756-767 12 p.

    Research output: Contribution to journal › Review › Research › peer-review

  86. Published

    Acute effects of dapagliflozin on renal oxygenation and perfusion in type 1 diabetes with albuminuria: A randomised, double-blind, placebo-controlled crossover trial

    Laursen, J. C., Søndergaard-Heinrich, N., de Melo, J. M. L., Haddock, B., Rasmussen, I. K. B., Safavimanesh, F., Hansen, C. S., Størling, Joachim, Larsson, Henrik Bo Wiberg, Groop, P., Frimodt-Møller, M., Andersen, U. B. & Rossing, Peter, 2021, In: EClinicalMedicine. 37, 10 p., 100895.

    Research output: Contribution to journal › Journal article › Research › peer-review

  87. Published

    Association of coding variants in hydroxysteroid 17-beta dehydrogenase 14 (HSD17B14) with reduced progression to end stage kidney disease in type 1 diabetes

    Mychaleckyj, J. C., Valo, E., Ichimura, T., Ahluwalia, T. S., Dina, C., Miller, R. G., Shabalin, I. G., Gyorgy, B., Cao, J. J., Onengut-Gumuscu, S., Satake, E., Smiles, A. M., Haukka, J. K., Tregouet, D. A., Costacou, T., O’Neil, K., Paterson, A. D., Forsblom, C., Keenan, H. A., Pezzolesi, M. G. & 16 others, Pragnell, M., Galecki, A., Rich, S. S., Sandholm, N., Klein, R., Klein, B. E., Susztak, K., Orchard, T. J., Korstanje, R., King, G. L., Hadjadj, S., Rossing, Peter, Bonventre, J. V., Groop, P. H., Warram, J. H. & Krolewski, A. S., 2021, In: Journal of the American Society of Nephrology. 32, 10, p. 2634-2651 18 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  88. Published

    Biomarkers for early detection of kidney disease: a call for pathophysiological relevance

    Siwy, J., Mischak, H., Beige, J., Rossing, Peter & Stegmayr, B., 2021, In: Kidney International. 99, 5, p. 1240-1241 2 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  89. Published

    Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes

    Pitt, B., Filippatos, G., Agarwal, R., Anker, S. D., Bakris, G. L., Rossing, Peter, Joseph, A., Kolkhof, P., Nowack, C., Schloemer, P., Ruilope, L. M. & FIGARO DKD Investigators, F. D. I., 2021, In: New England Journal of Medicine. 385, p. 2252-2263 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  90. Published

    Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes

    Bjerre-Christensen, T., Winther, S. A., Tofte, N., Theilade, S., Ahluwalia, Tarun Veer Singh, Lajer, M., Hansen, T. W., Rossing, Peter & Hansen, C. S., 2021, In: B M J Open Diabetes Research & Care. 9, 1, 9 p., e002289.

    Research output: Contribution to journal › Journal article › Research › peer-review

  91. Published

    Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial

    Persson, F., Bain, S. C., Mosenzon, O., Heerspink, H. J. L., Mann, J. F. E., Pratley, R., Raz, I., Idorn, T., Rasmussen, S., von Scholten, B. J., Rossing, Peter & LEADER Trial Investigators, L. T. I., 2021, In: Diabetes Care. 44, 3, 7 p., dc201622.

    Research output: Contribution to journal › Journal article › Research › peer-review

  92. Published

    Chronic Kidney Disease in Diabetes: Guidelines from KDIGO

    Khunti, K., De Boer, I. H. & Rossing, Peter, 2021, In: American Family Physician. 103, 11, p. 698-700

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  93. Published

    Circulating Free Fatty Acid and Phospholipid Signature Predicts Early Rapid Kidney Function Decline in Patients With Type 1 Diabetes

    Afshinnia, F., Rajendiran, T. M., He, C., Byun, J., Montemayor, D., Darshi, M., Tumova, J., Kim, J., Limonte, C. P., Miller, R. G., Costacou, T., Orchard, T. J., Ahluwalia, Tarun Veer Singh, Rossing, Peter, Snell-Bergeon, J. K., de Boer, I. H., Natarajan, L., Michailidis, G., Sharma, K. & Pennathur, S., 2021, In: Diabetes Care. 44, 9, p. 2098-2106 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  94. Published

    Comparison of Natriuretic Peptides as Risk Markers for All-Cause Mortality and Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes

    Tofte, N., Theilade, S., Winther, S. A., Birkelund, S., Goetze, Jens P. , Hansen, T. W. & Rossing, Peter, 2021, In: Diabetes Care. 44, 2, p. 595-603

    Research output: Contribution to journal › Journal article › Research › peer-review

  95. Published

    Data Sharing Under the General Data Protection Regulation: Time to Harmonize Law and Research Ethics?

    Vlahou, A., Hallinan, D., Apweiler, R., Argiles, A., Beige, J., Benigni, A., Bischoff, R., Black, P. C., Boehm, F., Céraline, J., Chrousos, G. P., Delles, C., Evenepoel, P., Fridolin, I., Glorieux, G., van Gool, A. J., Heidegger, I., Ioannidis, J. P. A., Jankowski, J., Jankowski, V. & 19 others, Jeronimo, C., Kamat, A. M., Masereeuw, R., Mayer, G., Mischak, H., Ortiz, A., Remuzzi, G., Rossing, Peter, Schanstra, J. P., Schmitz-Dräger, B. J., Spasovski, G., Staessen, J. A., Stamatialis, D., Stenvinkel, P., Wanner, C., Williams, S. B., Zannad, F., Zoccali, C. & Vanholder, R., 2021, In: Hypertension. 77, 4, p. 1029-1035

    Research output: Contribution to journal › Review › Research › peer-review

  96. Published

    Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline

    Navaneethan, S. D., Zoungas, S., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Liew, A., Michos, E. D., Olowu, W. A., Sadusky, T., Tandon, N., Tuttle, K. R., Wanner, C., Wilkens, K. G., Lytvyn, L., Craig, J. C., Tunnicliffe, D. J., Howell, M., Tonelli, M., Cheung, M. & 4 others, Earley, A., Rossing, Peter, de Boer, I. H. & Khunti, K., 2021, In: Annals of Internal Medicine. 174, 3, p. 385-398

    Research output: Contribution to journal › Journal article › Research › peer-review

  97. Published

    Distinct Molecular Signatures of Clinical Clusters in People With Type 2 Diabetes: An IMI-RHAPSODY Study

    Slieker, R. C., Donnelly, L. A., Fitipaldi, H., Bouland, G. A., Giordano, G. N., Åkerlund, M., Gerl, M. J., Ahlqvist, E., Ali, A., Dragan, I., Elders, P., Festa, A., Hansen, M. K., van der Heijden, A. A., Mansour Aly, D., Kim, M., Kuznetsov, D., Mehl, F., Klose, C., Simons, K. & 15 others, Pavo, I., Pullen, T. J., Suvitaival, T., Wretlind, A., Rossing, Peter, Lyssenko, V., Legido Quigley, C., Groop, L., Thorens, B., Franks, P. W., Ibberson, M., Rutter, G. A., Beulens, J. W. J., 't Hart, L. M. & Pearson, E. R., 2021, In: Diabetes. 70, 11, p. 2683-2693 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  98. Published

    Early response in albuminuria and long-term kidney protection during treatment with an endothelin receptor antagonist: A prespecified analysis from the SONAR trial

    Heerspink, H. J. L., Xie, D., Bakris, G., Correa-Rotter, R., Hou, F. F., Kitzman, D. W., Kohan, D., Makino, H., McMurray, J. J. V., Perkovic, V., Rossing, Peter, Parving, H. H. & de Zeeuw, D., 2021, In: Journal of the American Society of Nephrology. 32, 11, p. 2900-2911

    Research output: Contribution to journal › Journal article › Research › peer-review

  99. Published

    Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [64Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial

    Jensen, Jacob Kildevang, Zobel, E. H., von Scholten, B. J., Rotbain Curovic, V., Hansen, T. W., Rossing, Peter, Kjær, Andreas & Ripa, Rasmus Sejersten, 2021, In: Frontiers in Endocrinology. 12, 10 p., 790405.

    Research output: Contribution to journal › Journal article › Research › peer-review

  100. Published

    Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular Disease

    McMurray, J. J. V., Wheeler, D. C., Stefánsson, B. V., Jongs, N., Postmus, D., Correa-Rotter, R., Chertow, G. M., Greene, T., Held, C., Hou, F., Mann, J. F. E., Rossing, Peter, Sjöström, C. D., Toto, R. D., Langkilde, A. M., Heerspink, H. J. L. & DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2021, In: Circulation. 143, 5, p. 438-448

    Research output: Contribution to journal › Journal article › Research › peer-review

  101. Published

    Effect of Liraglutide on Arterial Inflammation Assessed as [F-18]FDG Uptake in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

    Ripa, Rasmus Sejersten, Zobel, E. H., von Scholten, B. J., Jensen, Jacob Kildevang, Binderup, Tina, Diaz, L. J., Curovic, V. R., Hansen, T. W., Rossing, Peter & Kjær, Andreas, 2021, In: Circulation: Cardiovascular Imaging. 14, 7, 13 p., 012174.

    Research output: Contribution to journal › Journal article › Research › peer-review

  102. Published

    Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial

    Heerspink, H. J. L., Jongs, N., Chertow, G. M., Langkilde, A. M., McMurray, J. J. V., Correa-Rotter, R., Rossing, Peter, Sjöström, C. D., Stefansson, B. V., Toto, R. D., Wheeler, D. C., Greene, T. & DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2021, In: The Lancet Diabetes and Endocrinology. 9, 11, p. 743-754 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  103. Published

    Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial

    Jongs, N., Greene, T., Chertow, G. M., McMurray, J. J. V., Langkilde, A. M., Correa-Rotter, R., Rossing, Peter, Sjöström, C. D., Stefansson, B. V., Toto, R. D., Wheeler, D. C., Heerspink, H. J. L. & DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2021, In: The Lancet Diabetes and Endocrinology. 9, 11, p. 755-766 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 Next

ID: 12937790